Publications:17
- Home
- Profiles
Margaret Smirnoff, MSc
- About Me
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Publications
Selected Publications
- Unifying Outpatient Practices to Redress Structural Racism in an Urban Health System. Sofia R. Schlozman, Margaret Smirnoff, Ann Scheck McAlearney, Carol R. Horowitz, Lynne D. Richardson, Radhi Yagnik, Nina A. Bickell. JAMA Health Forum
- Autoimmune conditions in the World Trade Center general responder cohort: A nested case-control and standardized incidence ratio analysis. Henry S. Sacks, Margaret Smirnoff, Deborah Carson, Michael L. Cooney, Moshe Z. Shapiro, Christopher J. Hahn, Christopher R. Dasaro, Cynthia Crowson, Ioannis Tassiulas, Robert P. Hirten, Benjamin L. Cohen, Richard S. Haber, Terry F. Davies, David M. Simpson, Michael A. Crane, Denise J. Harrison, Benjamin J. Luft, Jacqueline M. Moline, Iris G. Udasin, Andrew C. Todd, Nancy L. Sloan, Susan L. Teitelbaum. American Journal of Industrial Medicine
- Screening for human trafficking in one emergency department: Social acceptance and practical dissonance. Meg Smirnoff, Kristin Potterbusch, Cindy Clesca, Makini Chisolm-Straker. Academic Emergency Medicine
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Smirnoff has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Smirnoff has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.